Live Breaking News & Updates on Syndax Pharmaceuticals Trading

Stay updated with breaking news from Syndax pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stake Boosted by Algert Global LLC

Algert Global LLC increased its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 79.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 456,219 shares of the company’s stock after purchasing an additional 202,588 shares during the period. […] ....

Hong Kong , United States , Stifel Nicolaus , Quarter For Syndax Pharmaceuticals , Syndax Pharmaceuticals , Royal Bank , China Universal Asset Management Co , Syndax Pharmaceuticals Trading , Ameritas Investment Partners Inc , News Ratings For Syndax Pharmaceuticals Daily , Algert Global , Hong Kong Ltd , Syndax Pharmaceuticals Inc , Exchange Commission , Free Report , Universal Asset Management , Kong Ltd , Investment Management , Ameritas Investment Partners , Investment Partners , Syndax Pharmaceuticals Daily , Nasdaq Sndx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3.8%

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) shares traded down 3.8% during trading on Wednesday . The company traded as low as $20.43 and last traded at $20.43. 320,648 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 1,020,577 shares. The stock had previously closed at $21.23. […] ....

Hong Kong , Robertw Baird , Stifel Nicolaus , Annandale Capital , China Universal Asset Management Co , Syndax Pharmaceuticals Company Profile , Syndax Pharmaceuticals Trading , Hong Kong Ltd , Institutional Investors Weigh In On Syndax Pharmaceuticals , Syndax Pharmaceuticals , News Ratings For Syndax Pharmaceuticals Daily , Syndax Pharmaceuticals Inc , Royal Bank , Get Free Report , Universal Asset Management , Kong Ltd , Sandia Investment Management , Syndax Pharmaceuticals Daily , Nasdaq Sndx ,

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $35.09 Consensus Price Target from Analysts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has received a consensus rating of “Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have issued a report on the stock in […] ....

United States , Briggs Morrison , Syndax Pharmaceuticals Trading , Blackrock Inc , Analyst Recommendations For Syndax Pharmaceuticals , Vanguard Group Inc , Syndax Pharmaceuticals Company Profile , Jennison Associates , Insider Activity At Syndax Pharmaceuticals , Goldman Sachs Group , Syndax Pharmaceuticals , News Ratings For Syndax Pharmaceuticals Daily , Syndax Pharmaceuticals Inc , Get Free Report , Director Briggs Morrison , Street Corp , Capital Management , Get Free , Syndax Pharmaceuticals Daily , Nasdaq Sndx ,